Drug intelligence / Profile preview

evodia rutaecarpa

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Evodia rutaecarpa is a medicinal plant native to China and Korea and is widely used in Traditional Chinese Medicine (TCM) for over 2,000 years[1][5][6]. The dried fruit—often called "Evodiae Fructus" or "Wu Zhu Yu"—is the primary part used medicinally. It contains several active compounds including the indole alkaloids evodiamine and rutaecarpine[2][3][5][7]. These constituents are believed to be responsible for its pharmacological effects. Mechanistically: - **Evodiamine** exhibits analgesic (pain-relieving), anti-inflammatory, antitumor/cytotoxicity against cancer cells (including multidrug-resistant lines), cardiovascular protective effects (heart protection), metabolic regulation properties (weight loss/thermogenesis via vanilloid receptor agonism similar to capsaicin)[2][3][4][5][7]. - **Rutaecarpine** has antiplatelet activity by inhibiting phospholipase C and COX-2 inhibition; it also interacts with vanilloid receptors contributing to analgesic effects[1][8]. Traditional uses include treatment of gastrointestinal disorders such as diarrhea, vomiting/nausea/GERD/stomach pain/dysentery/lack of appetite; headaches; hypertension; inflammation; amenorrhea/menstrual pain/postpartum bleeding; obesity/metabolic syndrome; infections including parasitic worms[1][4][5]. Modern research supports some of these activities but also highlights potential hepatotoxicity and cardiotoxicity at high doses or with isolated compounds like evodiamine/rutaecarpine[2]. The herb may interact with drug-metabolizing enzymes such as CYP1A2 and can affect metabolism of drugs like caffeine/theophylline[4].

Brand names
Wu Zhu YuGosyuyuSan Cha KuWu-Chu-YuWu-Zhu-Yu
Other names
Evodia FruitEvodiae FructusEvodiamine (main alkaloid)Rutaecarpine (main alkaloid)Tetradium ruticarpum
02

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PLC (Phospholipase C family)

Beyond the preview

Go deeper on evodia rutaecarpa.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on evodia rutaecarpa.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call